InvestorsHub Logo
Followers 239
Posts 12042
Boards Moderated 0
Alias Born 08/14/2003

Re: blue_skies post# 249070

Saturday, 10/26/2019 11:34:17 PM

Saturday, October 26, 2019 11:34:17 PM

Post# of 689031
I'll agree with you that the company communicates little, but the company has permitted it's lead clinician to communicate lots. I've seen few companies that permitted or encouraged such open communication from the lead clinician for their trials.

I believe many companies believe their lead clinician to be very important. I've often seen trials delayed by several months because it would be months before the person they wanted to be their lead clinician was available. Certainly others could have started the trial sooner, but for whatever the reason, they wanted on particular Dr. and they were willing to wait.

As I understand it, Dr. Liau and UCLA were involved with the genesis of these vaccines, it's only natural for them to lead the development. I don't believe it's that uncommon to have that sort of situation where a research institution is involved in the development of the product.

I originally had the choice of going to UCLA or City of Hope, I'm sure I'd have had excellent care at UCLA, but I liked the feel I got when meeting the people at City of Hope. Both are top flight cancer institutions.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News